ARTICLE | Management Tracks
ITM names Cavey CEO, plus PureTech, Brainstorm and more
Plus: New chairs for PureTech, Evexta and updates from PharmaEssentia, Brainstorm, Danaher and more
June 21, 2024 11:25 PM UTC
Steffen Schuster is stepping down after serving as CEO for over 12 years at ITM Isotope Technologies Munich SE, a radiopharmaceuticals company. Schuster, who will join the board, will be succeeded by Andrew Cavey on Sept. 1. Cavey was SVP, head of global program leaders, hematology, oncology, cell therapy at Bristol Myers Squibb Co. (NYSE:BMY).
Two companies, PureTech Health plc (LSE:PRTC; NASDAQ:PRTC) and Evexta Bio S.A., named new chairs. ...